Statements (57)
Predicate | Object |
---|---|
gptkbp:instanceOf |
recreational drug
synthetic stimulant |
gptkbp:abusePotential |
yes
|
gptkbp:became_popular |
2000s
|
gptkbp:broadcastOn |
gptkb:Class_B_(UK)
gptkb:Schedule_III_(Canada) gptkb:Schedule_I_(US) Anlage I (Germany) |
gptkbp:chemicalFormula |
C11H15NO
|
gptkbp:detects |
blood
urine hair |
gptkbp:drugClass |
cathinone
|
gptkbp:effect |
euphoria
increased sociability stimulation |
gptkbp:excretion |
kidneys
|
gptkbp:firstSynthesized |
1929
|
gptkbp:halfLife |
2-4 hours
|
gptkbp:hasStreet |
gptkb:helicopter
bubbles M-CAT meow meow |
https://www.w3.org/2000/01/rdf-schema#label |
mephedrone
|
gptkbp:IUPACName |
2-methylamino-1-(4-methylphenyl)propan-1-one
|
gptkbp:legalStatus |
illegal in many countries
|
gptkbp:mechanismOfAction |
norepinephrine reuptake inhibitor
dopamine reuptake inhibitor monoamine releaser |
gptkbp:meltingPoint |
about 207°C
|
gptkbp:metabolism |
liver
|
gptkbp:molecularWeight |
177.24 g/mol
|
gptkbp:origin |
laboratory synthesis
|
gptkbp:otherName |
gptkb:MCAT
4-MMC 4-methylmethcathinone meow meow |
gptkbp:relatedTo |
amphetamine
cathinone methcathinone |
gptkbp:riskFactor |
overdose
neurotoxicity cardiotoxicity |
gptkbp:routeOfAdministration |
injection
oral insufflation rectal |
gptkbp:sideEffect |
nausea
anxiety paranoia increased heart rate insomnia |
gptkbp:toxicity |
high in overdose
|
gptkbp:usedFor |
party drug
|
gptkbp:bfsParent |
gptkb:Methylone
gptkb:Methadrone |
gptkbp:bfsLayer |
7
|